Tel：886-2-2875-7434*333
Fax：886-2-2875-7435
Email：dr.wu.taiwan@gmail.com

Education

Ph.D. National Taiwan University, Taipei, Taiwan, 2001/9~2007/1

Concentration: Translational medicine and cancer biomarkers

LL.M. Harvard Law School, Cambridge, Massachusetts, USA, 2002/9~2003/6

Concentration: Health law and biotechnology regulation

LL.B. Tunghai University, Taichung, Taiwan, 1996/9~2000/6

Major: Law

MPH Harvard School of Public Health, Cambridge, Massachusetts, USA, 1992/9~1993/6

Concentration: Quantitative method and research methodology

M.D. National Taiwan University, Taipei, Taiwan, 1984/9~1991/6

Major: Medicine

Professional Appointment

Director of Division of Translational Research, Taipei Veterans General Hospital, 2017/10~

Professor of Gastroenterology, Taipei Veterans General Hospital; 2017/10~

Director of Excellent Cancer Research Center, Taipei Veterans General Hospital, 2019/1~

Joint Appointment Researcher, National Institute of Cancer Research, National Health Research Institutes, 2014/8~

Joint Appointment Professor, Institute of Clinical Medicine & Institute of Public Health, National Yang-Ming University, 2012/8~

Joint Appointment Professor, Department of Public Health, China Medical University, 2012/8~

Joint Appointment Professor, College of Law, Tunghai University, 2012/8~

Member of Institute Review Board, National Health Research Institutes, 2007/8~

Member of Committee of Medical Care Dispute Assessment, Ministry of Health and Welfare, 2014/1~

Member of Administrative Appeal Review Committee, Ministry of Health and Welfare, 2019/1~

Member of Medical Particle Therapy Review Committee, Ministry of Health and Welfare, 2019/1~

Member of Arbitration Committee of Industrial Dispute, Ministry of Labor, 2017/7~

Member of National Examination Committee, Ministry of Examination, 2009/7~

Consultant, Think tank of Medical Law, Taiwan Medical Association, 2006/1~

Consultant, Financial Ombudsman Institution, 2012/3~

Founding President, Taiwan Microbiota Consortium, 2017/3~

Editor-in-Chief, Advances in Digestive Medicine, 2016/11~

Editor, Gut, 2016/3~

Editor, Journal of Gastroenterology and Hepatology, 2019/1~

Executive Director, Society of Law and Medicine, Taiwan, 2018/8~

Executive Supervisor, Taiwan Evidence-Based Medicine Association, 2007/8~

Director, Taiwan Liver Cancer Association, 2012/5~

RESEARCH INTERESTS

Digestive cancers translational research

Big data research

Microbiome research

Empirical study of medical malpractice

Biotechnology regulation

Patents

Statin for gastric cancer treatment (Certificated number: I607751)

Hepatitis B virus quantitative detection methods, (Certificated number: I586809 & I530685)

Intestinal microbe therapy, composition therefor and method for preparing the same (Certificated number: I636789)

Gastric cancer biomarker screening (Certificated number: I507412)

Awards

2018 Medical Model Award, Taiwan Medical Association

2016 National Innovation Award, Taiwan Institute for Biotechnology & Medicine Industry;

2015 Outstanding Research Award, Taiwan’s Ministry of Science & Technology;

2015 Emerging Leadership Award, Asia-Pacific Digestive Week.

2010-2013 Best Teaching Awards, National Yang-Ming University.

Publications

1. Wu PC, Wu CY, Lyu YS, Chang YT, Wu CY. Association between bullous pemphigoid and atopic dermatitis: a population-based case-control study in Taiwan.

Arch Dermatol Res. 2022 Jul 14.

2. Saini V, Liang LL, Yang YC, Le HM, Wu CY. The Association Between Dissemination and Characteristics of Pro-/Anti-COVID-19 Vaccine Messages on Twitter: Application of the Elaboration Likelihood Model.

JMIR Infodemiology. 2022 Jun 27;2(1):e37077.

3. Liu JJ, De Vivo I, Wu CY, Giovannucci E. Subsequent primary urogenital cancers among childhood and adolescent cancer survivors in the United States.

Urol Oncol. 2022 Feb;40(2):65.e11-65.e18.

4. Lee PC, Chang TE, Wang YP, Lee KC, Lin YT, Chiou JJ, Huang CW, Yang UC, Li FY, Huang HC, Wu CY, Huang YH, Hou MC. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.

J Formos Med Assoc. 2022 Sep;121(9):1636-1646.

5. Chu CS, Yang CY, Yeh CC, Lin RT, Chen CC, Bai LY, Hung MC, Lin CC, Wu CY, Lin JT. Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: a pilot study.

Sci Rep. 2022 Jan 7;12(1):107.

6. Chou YJ, Wu CY, Pan TY, Wu CY, Chang YT. Risk of malignancy in patients with psoriasis receiving systemic medications: A nested case-control study.

Dermatol Ther 2022 Sep 6:e15804 (Epub ahead of print).

7. Ma SH, Wu CY, Lyu YS, Chou YJ, Chang YT, Wu CY. Association between sodium-glucose co-transporter 2 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a nationwide population-based cohort study.

J Eur Acad Dermatol Venerol 2022 July; 36(7): 1097-1103 (SCI, IF 9.228; 4/68; Dermatology)

8. Li CL, Ma SH, Wu CY, Chang PH, Chang TY, Wu CY. Association between sensorineural hearing loss and vitiligo: a nationwide-based cohort study.

J Eur Acad Dermatol Venerol 2022 July; 36(7): 1097-1103 (SCI, IF 9.228; 4/68; Dermatology)

9. Chen CL, Wu CY, Lyu YS, Chou YJ, Chang TY, Wu CY. Association between bullous pemphigoid and risk of venous thromboembolism: a nationwide population-based cohort study.

J Dermatol 2022 May 2; Online ahead of print (SCI, IF 3.468, 22/68; Dermatology).

10. Lin TL, Fan YH, Chang YL, Ho HJ, Wu CY*, Chen YJ. Early-life infections in association with the development of atopic dermatitis in infancy and early childhood: a nationwide nested case-control study.

J Eur Acad Dermatol Venereol 2022 Apr; 36(4):615-22 (SCI, IF 9.228; 4/68; Dermatology)

11. Hsu YC, Chen CC, Lee WH, Chang CY, Lee FJ, Tseng CH, Chen ZH, Ho HJ, Lin JT, Wu CY*. Compositions of Gut Microbiota Before and Shortly After Hepatitis C Viral Eradication by Direct Antiviral Agents.

Sci Rep 2022 Mar 31; 12(1)5481 (SCI, IF 4.996, 19/73; Multidisciplinary sciences).

12. Lin TL, Fan YH, Chang YL, Ho HJ, Liang LL, Chen YJ, Wu CY*. Early-life exposure associated with varicella occurrence and breakthrough infection: evidence from nationwide pre-vaccination and post-vaccination cohorts.

Front Immunol 2022 Mar 31;13:848835 (SCI, IF 8.786, 33/161, Immunology).

13. Hsu YC, Suri V, Nguyen MH, Huang YT, Chen CY, Chang IW, Tseng CH, Wu CY, Lin JT, Pan DZ, Gaggar A, Podlaha O. Inhibition of viral replication reduces transcriptionally active distinct hepatitis B virus integrations with implications on host gene dysregulation.

Gastroenterology 2022 Jan 5: S0016-5085(22)00006-3 (SCI, IF 33.883, 3/93; Gastroenterology & Hepatology).

14. Lin TL, Wu CY, Fan YH, Chang YL, Ho HJ, Chen YJ. Association between early life laxative exposure and risk of allergic diseases.

Ann Allergy Asthma Immunol 2022 Jan 5; S1081-1206(21)01341-7 (SCI, IF 6.248, 9/27; Allergy).

15. Lin TL, Wu CY, Juan CK, Chang YT, Chen YJ. Long-Term Risk of Autoimmune Diseases other than Systemic Lupus Erythematosus in Cutaneous Lupus Erythematosus-Alone Patients: A 10-Year Nationwide Cohort Study.

Dermatology 2022; 238(1): 92-100 (SCI, IF 5.197, 11/68; Dermatology).

16. Lin TL, Wu CY, Yen JJY, Juan CK, Chang YL, Ho HJ, Chen YJ. Fracture risk in patients with atopic dermatitis: a nationwide matched cohort study reply.

Ann Allergy Asthma Immunol 2022 Feb; 128(2): 231 (SCI, IF 6.248, 9/27; Allergy).

17. Wu CY, Wu CY, Li CP, Lin YH, Chang YT. Association of immunosuppressants with mortality of patients with bullous pemphigoid: a nationwide population-based cohort study.

Dermatology 2022; 238(2):378-385 (SCI, IF 5.197, 11/68; Dermatology).

18. Weng YC, Ho HJ, Chang YL, Chang YT, Wu CY*, Chen YJ. Reduced risk of skin cancer and internal malignancies in vitiligo patients: a retrospective population-based cohort study in Taiwan.

Sci Rep 2021 Oct 12; 11(1): 20195 (SCI, IF 4.996, 19/73; Multidisciplinary sciences).

19. Lin TL, Wu CY, Yen JJY, Juan CK, Chang YL, Ho HJ, Chen YJ. Fracture risk in patients with atopic dermatitis: a nationwide matched cohort study.

Ann Allergy Asthma Immunol 2021 Dec; 127(6): 667-673.e2 (SCI, IF 6.248, 9/27; Allergy).

20. Liang LL, Kao CT, Ho HJ, Wu CY*. COVID-19 case doubling time associated with non-pharmaceutical interventions and vaccination: a global experience.

J Global Health 2021 Sep 4; 11: 05021 (SCI, IF 7.664, 28/301; Public, Environmental medicine & Occupational health).

21. Chen YJ, Ho HJ, Wu CY, Juan CK, Wu CY*. Infantile infection and antibiotic exposure in association with pediatric psoriasis development: a nationwide nested case-control study.

J Am Acad Dermatol 2021 Sep; 85(3): 626-35 (SCI, IF 15.487, 1/68; Dermatology).

22. Chang SH, Wu CY, Chuang KC, Huang SW, Li ZH, Wang ST, Lai ZL, Chang CC, Chen YJ, Wong TW, Kao JK, Shieh JJ. Imiquimod accelerated antitumor response by targeting lysosome adaptation in skin cancer cells.

J Invest Dermatol 2021 Sep; 141(9): 2219-28 (SCI, IF 7.590, 5/68; Dermatology).

23. Wu CY*, Ho HJ, Wu CY, Chen YJ, Lee TY, Hsu YC, Lin JT. Association between proton pump inhibitor use and mortality in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor.

Gut 2021 Sep 9; gutjnl-2020-321932 (SCI, IF 33.883, 3/93; Gastroenterology & Hepatology).

24. Liang LL, Kuo HS, Ho HJ, Wu CY*. COVID-19 vaccinations are associated with reduced fatality rates: evidence from cross-country quasi-experiments.

J Global Health 2021 July 17; 11:05019. (SCI, IF 7.664, 28/301; Public, Environmental medicine & Occupational health).

25. Hsu YC, Chen CY, Chang IW, Chang CY, Wu CY, Lee TY, Wu MS, Bair MJ, Chen JJ, Chen CC, Tseng CH, Tai CM, Huang YT, Ku WH, Ro LR, Lin JT. Once-daily tenofovir disoproxil fumarate in treatment-naïve Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomized trial.

Lancet Infect Dis 2021 Jun; 21(6): 823-33 (SCI, IF 71.421, 2/94; Infectious diseases)

26. Liu JJ, Chen CY, Giovannucci E, Wu CY. Subsequent primary cancers of the digestive system among childhood and adolescent cancer survivors from 1975 to 2015 in the United States.

Am J Gastroenterol 2021 May 1; 116(5): 1063-71 (SCI, IF 12.045, 9/93; Gastroenterology & Hepatology).

27. Tseng CH, Hsu YC, Ho HJ, Nguyen MH, Wu CY*. Increasing age and non-liver comorbidities in patients with chronic hepatitis B in Taiwan: a nationwide population-based analysis.

Dig Dis 2021 May; 39(3): 266-74 (SCI, IF 3.421, 58/93; Gastroenterology & Hepatology).

28. Weng YC, Juan CK, Ho HJ, Chang YL, Wu CY*, Chen YJ. Atopic dermatitis does not increase the risk of inflammation bowel disease: a nationwide cohort study.

J Dermatol 2021 Feb; 48(2): 168-74 (SCI, IF 3.468, 22/68; Dermatology).

29. Lin YT, Lin TY, Hung SC, Liu PY, Wu PH, Chuang YS, Hung WC, Chiu YW, Kuo MC, Wu CY. Anti-acid drug treatment induces changes in the gut microbiome composition of hemodialysis patients.

Microorganisms 2021 Jan 30; 9(2): 286 (SCI, IF 4.926, 54/136; Microbiology).

30. Wu CY, Wu CY, Li CP, Chou YJ, Lin YH, Chang YT. Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a population-based cohort study.

Diabetes Res Clin Pract 2021 Jan; 171: 108546 (SCI, IF 8.180, 20/145; Endocrine & Metabolism).

31. Chen YJ, Lee WH, Ho HJ, Tseng CH, Wu CY*. An altered fecal microbial profiling in rosacea patients compared to matched controls.

J Formos Med Assoc 2021 Jan; 120(1 Pt 1): 256-64 (SCI, IF 3.871, 61/172; Medicine, General & Internal).

32. Wu PH, Liu PY, Chiu YW, Hung WC, Lin YT, Hung SC, Delican RA, Kuo MC, Wu CY. Comparative gut microbiome differences between ferric citrate and calcium carbonate phosphage binders in patients with end-stage kidney disease.

Microorganisms 2020 Dec 20; 8(12): 2040 (SCI, IF 4.926, 54/136; Microbiology).

33. Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, …, Wu CY, … Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.

Gut 2020 Dec; 69(12): 2093-112 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology)

34. Lee TY, Hsu YC, Tseng HC, Lin JT, Wu MS, Wu CY*. Association of daily aspirin therapy with hepatocellular carcinoma risk in patients with chronic hepatitis C virus infection.

Clin Gastroenterol Hepatol 2020 Nov; 18(12): 2784-92.e7 (SCI, IF 13.576, 7/93; Gastroenterology & Hepatology).

35. Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe?

Gut 2020 Oct; 69(10): 1867-76 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology).

36. Huang SW, Wang ST, Chang SH, Chunag KC, Wang HY, Kao JK, Liang SM, Wu CY, Kao SH, Chen YJ, Shieh JJ. Imiquimod exerts antitumor effects by inducing immunogenic cell death and is enhanced by the glycolytic inhibitor 2-deoxyglucose.

J Invest Dermatol 2020 Sep; 140(9): 1771-83 (SCI, IF 7.590, 5/68; Dermatology).

37. Yeo YH, Tseng TC, Hosaka T, … Wu CY,… Nguyen M. Incidence, factors, and patient-level data for spontaneous HBsAg seroclearance: a cohort study of 11, 264 patients.

J Clin Transl Hepatol 2020 Sep; 11 (9): e00196 (SCI, IF 5.065, 36/93; Gastroenterology & Hepatology).

38. Chen YJ, Juan CK, Chang YT, Wu CY*, Ho HJ, Tseng CH. Association between inflammatory bowel disease and bullous pemphigoid: a population-based case-control study.

Sci Rep 2020 Jul 29; 10(1): 12727 (SCI, IF 4.996, 19/73; Multidisciplinary sciences).

39. Liang LL, Tseng CH, Ho HJ, Wu CY*. Covid-19 mortality is negatively associated with test number and government effectiveness.

Sci Rep 2020 Jul 24;10(1):12567 (SCI, IF 4.996, 19/73; Multidisciplinary sciences).

40. Wang ST, Huang SW, Liu KT, Lee TY, Shieh JJ, Wu CY*. Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway.

Cell Death Discovery 2020 Mar 30; 6(1); 17 (SCI, IF 7.109, 57/194; Cell Biology). 

41. Su CW, Wu CY, Lin JT, Ho HJ, Wu CJ. Nucleos(t)ide analogue continuous therapy associated with reduced adverse outcomes of chronic hepatitis B.

J Chin Med Assoc 2020 Feb; 83(2): 125-33 (SCI, IF 3.396, 71/172; Medicine, General & Internal). 

42. Chang TS, Ho HJ, Chang YT, Li CP, Wu CY, Wu CY. Is rosacea a risk factor for cancer: a population-based cohort study in Taiwan.

Dermatol Sin 2020 Feb; 38: 15-21 (SCI, IF 1.107, 63/68; Dermatology).

43. Liang RY, Liu BH, Huang CJ, Lin KT, Ko CC, Huang LL, Hsu B, Wu CY, Chuang SM. MEK2 is a critical modulating mechanism to down-regulate GCIP stability and function in cancer cells.

FASEB J 2020 Feb; 34(2): 1958-69 (SCI, IF 5.834, 77/194; Cell Biology).

44. Ng SC, Kamm MA, Yeoh YK, Chan PKS, Zuo T, Tang W, Sood A, Andoh A, Ohmiya N, Zhou Y, Ooi CJ, Mahachai V, Wu CY, Zhang F, Sugano K, Chan FKL. Scientific frontiers in faecal microbiota transplantation: joint document of AsiaPacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE).

Gut 2020 Jan; 69(1): 83-91 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology).

45. Wu CY*. Initiatives for a Healthy Stomach (Review).

Curr Treat Options Gastroenterol 2019 Dec; 17(4): 628-35.

46. Hsu WF, Yu SH, Lin JT, Wu JC, Hou MC, Huang YH, Wu CY*, Peng CY. Renal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with liver cirrhosis: a nationwide cohort study.

Gastroenterol Res Pract 2019 Oct 10; 2019:1 (SCI, IF 1.919, 87/93; Gastroenterology & Hepatology).

47. Wu CY*. Microbiota alterations after colon adenoma resection (Editorial).

J Gastroenterol Hepatol 2019 Oct 1; 34(10): 1669-70 (SCI, IF 4.369, 43/93; Gastroenterology & Hepatology).

48. Lee TY, Hsu YC, Tseng HC, Yu SH, Lin JT, Wu MS, Wu CY*. Association of daily aspirin therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B.

JAMA Intern Med 2019 May 1; 179(5): 633-40 (SCI, IF 44.409, 7/172; Medicine, General & Internal).

49. Lin TL, Wu CY, Chang YT, Juan CK, Chen CC, Yu SH, Chen YJ. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: results from a Taiwanese population-based cohort study.

Photodermatol Photoimmunol Photomed 2019 May; 35(3): 165-71 (SCI) (SCI, IF 3.254, 25/68; Dermatology)

50. Wong SH, Kwong TNY, Wu CY, Yu J. Clinical applications of gut microbiota in cancer biology

Semin Cancer Biol 2019 Apr; 55:28-36 (SCI, IF 17.012, 15/245; Oncology)

51. Tseng CH, Wu CY*. The gut microbiota in obesity (review).

J Formos Med Assoc 2019 Mar; 118 Suppl 1: S3-S9 (SCI, IF 3.871, 61/172; Medicine, General & Internal).

52. Yeo YH, Ho HJ, Yang HI…, Wu CY*, Nguyen MH. Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis.

Gastroenterology 2019 Feb; 156(3): 635-46 (SCI, IF 33.883, 3/93; Gastroenterology & Hepatology).

53. Yeo YH, Hsu CC, Lee CC, Ho HJ, Lin JT, Wu MS, Liou JM, Wu CY*. Systematic review with network meta-analysis: effectiveness of therapies for second-line Helicobacter pylori eradication.

J Gastroenterol Hepatol 2019 Jan; 34(1): 59-67 (SCI, IF 4.369, 43/93; Gastroenterology & Hepatology).

54. Hsu YC, Nguyen MH, Mo LR, Wu MS, Yang YH, Chen CC, Tseng CH, Tai CM, Wu CY, Lin JT, Tanaka Y, Chang CY. Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk.

Aliment Pharmacol Ther 2019 Jan; 49(1): 107-15 (SCI, IF 9.524, 17/279; Pharmacology & Pharmacy).

55. Chen YJ, Ho HJ, Tseng CH, Lai ZL, Shieh JJ, Wu CY*. Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients.

Exp Dermatol 2018 Dec;27(12):1336-43 (SCI, IF 4.511, 15/68; Dermatology).

56. Lai ZL, Tseng CH, Ho HJ, Cheung CKY, Lin JY, Chen YJ, Cheng FC, Hsu YC, Lin JT, El-Omar EM, Wu CY*. Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice.

Sci Rep 2018 Oct 23; 8(1): 15625 (SCI, IF 4.996, 19/73; Multidisciplinary sciences).

57. Cheng HC, Liou JM, Lou JC, Chiu CT, Wu MS, Yee YC, Wu CY, Wu DC, Hsu PI, Chang CC, Chang WL, Lin JT, Sheu BS. The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus.

Helicobacter 2018 Oct;23(5):e12533 (SCI, IF 5.182, 34/93; Gastroenterology & Hepatology).

58. Hsu YC, Yip TCF, Ho HJ, Wong VWS, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GLH, Wu CY*. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.

J Hepatol 2018 Aug; 69(2): 278-85 (SCI, IF 30.083, 5/93; Gastroenterology & Hepatology).

59. Lee TY, Hsu YC, Yu SH, Lin JT, Wu MS, Wu CY*. Effect of nucleos(t)ide analogue therapy on risk of intrahepatic cholangiocarcinoma in chronic hepatitis B.

Clin Gastroenterol Hepatol 2018 Jun; 16(6): 947-54.e4 (SCI, IF 13.576, 7/93; Gastroenterology & Hepatology).

60. Tsai HJ, Chuang YW, Lee SW, Wu CY, Yeh HZ, Lee TY. Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients.

Aliment Pharmacol Ther 2018 Jun;47(12):1673-81 (SCI, IF 9.524, 17/279; Pharmacology & Pharmacy).

61. Hsu YC, Ho HJ, Lee TY, Huang YT, Wu MS, Lin JT, Wu CY*, El-Serag HB. Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenoforvir.

J Viral Hepat 2018 May; 25(5): 543-51 (SCI, IF 3.517, 56/93; Gastroenterology & Hepatology).

62. Liou JM, Sheu BS, Lee YC, Cheng HC, Chang WL, We DC, Hsu PI, Wu CY, Wu MS, Chiu CT, Lin JT. Survey of the adherence to the consensus of gastroesophageal reflux disease before and after the implementation course.

J Formos Med Assoc 2018 May; 117(5): 440-9 (SCI, IF 3.871, 61/172; Medicine, General & Internal).

63. Yeo YH, Shiu SI, Ho HJ, Zou B, Lin JT, Wu MS, Liou JM, Wu CY*. First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis.

Gut 2018 Jan; 67(1): 20-7 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology).

64. Leung WK, Hsiu JH, Lin JT, Wu MS, Wu CY*. Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study.

Gastroint Endosc 2018 Jan; 87(1): 119-27 (SCI, IF 10.396, 10/93; Gastroenterology & Hepatology).

65. Liao YJ, Li YC, Lee SW, Wu CY, Yang SS, Yeh YZ, Chang CS, Lee TY. Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-up.

J Chin Med Assoc 2017 Dec; 80(12): 758-65 (SCI, IF 2.743, 62/167; Medicine, General & Internal).

66. Chien NH, Huang YT, Wu CY, Chang CY, Wu MS, Kao JH, Mo LR, Tai CM, Lin CW, Yang TH, Lin JT. Hsu YC. Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off NA-therapy.

BMC Gastroenterol 2017 Dec 8; 17(1); 154. doi: 10.1186/s12876-017-0697-3 (SCI, IF 2.847, 73/93; Gastroenterology & Hepatology).

67. Meistere I, Wemer S, Zayakin P, Silina K, Rulle U, Psmennaja A, Santare D, Kijuste I, Isajevs S, Leja M, Kupcinskas L, Kupcinskas J. Jonaitis L, Wu CY, Brenner H, Line A, Kalnina Z. The prevalence of cancer-associated autoantibodies in patients with gastric cancer and progressive grades of premalignant lesions.

Cancer Epidemiol Biomarkers Prev 2017 Oct; 26(10): 1564-74 (SCI, IF 4.090, 99/301; Public,

Environmental & Occupational Health).

68. Lee TY, Wu JC, Yu SH, Lin JT, Wu MS, Wu CY*. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically non-cirrhotic non-alcoholic fatty liver disease.

Int J Cancer 2017 Oct 1; 141(7): 1307-14 (SCI, IF 7.316, 52/245; Oncology).

69. Hsu YC, Mo LR, Chang CY, Wu MS, Yang TH, Kao JH, Chen CC, Tseng CH, Tai CM, Lin CW, Wu CY*, Lin JT. Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy. 

J Gastroenterol Hepatol 2017 Aug; 32(8): 1512-9 (SCI, IF 4.369, 43/93; Gastroenterology & Hepatology).

70. Chang SH, Huang SW, Wang ST, Chung KC, Hsieh CW, Kao JK, Chen YJ, Wu CY*, Shieh JJ. Imiquimod-induced autophagy is regulated by ER stress-mediated PKR activation in cancer cells.

J Dermatol Sci 2017 Aug; 87(2): 138-48 (SCI, IF 5.408, 9/68; Dermatology).

71. Sheu BS, Wu MS, Chiu CT, Lo JC, Wu DC, Liou JM, Wu CY, Cheng HC, Lee YC, Hsu PI, Chang CC, Chang WL, Lin JT. Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale. 

Helicobacter 2017 Jun 22(3): e12368 (SCI, IF 5.182, 34/93; Gastroenterology & Hepatology).

72. Wu CY, Chang YT, Juan CK, Shieh JJ, Lin YP, Liu HN, Lin JT, Chen YJ. Risk of inflammatory bowel disease in rosacea patients: results from a nationwide cohort study.

J Am Acad Dermatol 2017 May; 76(5): 911-7 (SCI, IF 15.487, 1/68; Dermatology).

73. Wang ST, Ho HJ, Lin JT, Shieh JJ, Wu CY* (corresponding author). Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.

Cell Death & Disease 2017 Feb 23; 8(2): e2626 (SCI, IF 9.685, 35/194; Cell Biology).

74. Lee LH, Hwang JI, Cheng YC, Wu CY, Lee SW, Yang SS, Yeh HZ, Chang CS, Lee TY. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.

PLos One 2017 Jan 9; 12(1):e0169655 (SCI, IF 3.752, 29/73; Multidisciplinary sciences)

75. Hsu YC, Mo LR, Chang CY, Wu MS, Kao JH, Wang WL, Yang TH, Wang CS, Chiang MF, Chen CC, Fang YJ, Hung HW, Wu CY*, Lin JT. Association between serum level of hepatitis B surface antigen at end of entecavir therapy and risk of relapse in e antigen-negative patients.

Clin Gastroenterol Hepatol 2016 Oct; 14(10): 1490-8 (SCI, IF 13.576, 7/93; Gastroenterology & Hepatology).

76. Chang WT, Weng SF, Hsu CH, Shih JY, Wang JJ, Wu CY, Chen ZC. Prognostic factors in patients with pulmonary hypertension: a nationwide cohort study.

J Am Heart Assoc 2016 Aug 29; 5(9): e003579 (SCI, IF 6.106, 42/143; Cardiac & Cardiovascular Systems).

77. Lee TY, Wang ZC, Lee YC, Ho HJ, Lin JT, Hsieh MC, Lan HY, Wu CY*. The incidence of gastric adenocarcinoma among patients with gastric intestinal metaplasia: a long-term cohort study.

J Clin Gastroenterol 2016 Aug; 50(7): 532-7 (SCI, IF 3.174, 70/93; Gastroenterology & Hepatology).

78. Wu CY, Chang YT, Juan CK, Shen JL, Lin YP, Shieh JJ, Liu HN, Chen YJ. Depression and insomnia in patients with psoriasis and psoriatic arthritis taking tumor necrosis factor antagonists.

Medicine 2016 May; 95(22): e3816 (SCI, IF 1.889, 99/167; Medicine, General & Internal)

79. Lee TY, Lin JT, Zeng YS, Chen YJ, Wu MS, Wu CY*. Association between nucleos(t)ide analogues and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma following radiofrequency ablation.

Hepatology 2016 May; 63(5): 1517-27 (SCI, IF 17.298, 6/93; Gastroenterology & Hepatology).

80. Wu CY, Hsu YC, Ho HJ, Chen YJ, Lee TY, Lin JT. Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study.

Gut 2016 Apr; 65(4): 693-701 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology).

81. Chen CC, Lai ZL, Wang GJ, Wu CY*. Polymerase chain reaction-free detection of hepatitis B virus DNA using a nanostructured impedance biosensor.

Biosens Bioelectron 2016 Mar 15; 77:603-8 (SCI, IF 10.618, 7/15; Biotechnology & Applied Microbiology).

82. Tseng CH, Lin JT, Ho HJ, Lai ZL, Wang CB, Tang SL, Wu CY*. Gastric microbiota and predicted gene function are altered after subtotal gastrectomy in patients with gastric cancer.

Sci Rep 2016 Feb 10; 6:20701 (SCI, IF 4.996, 19/73; Multidisciplinary sciences).

83. Wu CY, Lin JT. The changing epidemiology of Asian digestive cancers: from etiologies and incidences to preventive strategies.

Best Pract Res Clin Gastroenterol 2015 Dec;29(6):843-53 (SCI, IF 2.695, 77/93; Gastroenterology & Hepatology).

84. Chang CY, Wu CY*. Barrett’s esophagus and esophageal adenocarcinoma: east versus west.

Advances in Digestive Medicine 2015 Dec 1; 2(4): 121-2. 

85. Yang CY, Chen CH, Deng ST, Huang CS, Lin YJ, Chen YJ, Wu CY, Hung SI, Chung WH. Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan.

JAMA Intern Med 2015 Sep 1; 175(9): 1550-7 (SCI, IF 44.409, 7/172; Medicine, General & Internal).

86. Lee TY, Lin JT, Ho HJ, Wu MS, Wu CY*. Evaluation of the effect of cumulative operator experience on hepatocellular carcinoma recurrence after primary treatment with radiofrequency ablation.

Radiology 2015 Jul; 276(1): 294-301 (SCI, IF 29.146, 1/136; Radiology, Nuclear medicine & Medical imaging).

87. Shieh JJ, Wang ST, Huang SW, Kao JK, Liang SM, Chen YJ, Chen YY, Wu CY*. Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy.

J Dermatol Sci 2015 May; 78(2): 108-16 (SCI, IF 5.408, 9/68; Dermatology).

88. Hsu YC, Wu CY, Lin JT. Hepatitis C virus infection, antiviral therapy, and risk of hepatocellular carcinoma.

Semin Oncol 2015 Apr; 42(2): 329-38 (SCI, IF 4.929, 93/241; Oncology).

89. Hsu YC, Ho HJ, Huang YT, Wang HH, Wu MS, Lin JT, Wu CY*. Association between antiviral therapy and extrahepatic outcomes in patients with hepatitis C virus infection.

Gut 2015 Mar;64(3): 495-503 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology).

90. Yeh CC, Lin JT, Jeng LB, Ho HJ, Yang HR, Wu MS, Kuo KN, Wu CY*. Non-steroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: a nationwide cohort study.

Ann Surg 2015 Mar;261(3):521-6 (SCI, IF 13.787, 2/211; Surgery).

91. Lee TY, Wang CB, Chen TT, Kuo KN, Wu MS, Lin JT, Wu CY*. A tool to predict risk for gastric cancer in patients with peptic ulcer diseases, based on a nationwide cohort.

Clin Gastroenterol Hepatol 2015 Feb;13(2):287-93.e1 (SCI, IF 13.576, 7/93; Gastroenterology & Hepatology).

92. Wu CY, Shieh JJ, Shen JL, Liu YY, Chang YT, Chen YJ. Association between antidiabetic drugs and psoriasis risk in diabetic patients: Results from a nationwide nested case-control study in Taiwan.

J Am Acad Dermatol 2015 Jan; 72(1): 123-30 (SCI, IF 15.487, 1/68; Dermatology).

93. Wu CY, Chen DY, Shen JL, Ho HJ, Chen CC, Kuo KN, Liu HN, Chang YT, Chen YJ. The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.

Arthritis Research & Therapy 2014 Sep 30; 16(5): 449 (SCI, IF 5.156, 9/34; Rheumatology).

94. Lee TY, Chiang EP, Shih TY, Lane HY, Lin JT, Wu CY*. Lower serum folate is associated with development and invasiveness of gastric cancer.

World J Gastroenterol 2014 Aug 28; 20(32): 11312-20 (SCI, IF 5.374, 31/93; Gastroenterology & Hepatology).

95. Sheu BS, Wu CY (co-first author), Wu MS, Chiu CT, Lin CC, Hsu PI, Cheng HC, Lee TY, Wang HP, Lin JT. Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance.

Biomed Research International 2014 Aug 14; 563707 (SCI, IF 3.411, 80/140; Medicine, Research & Experimental).

96. Wu CY, Lin JT, Ho HJ, Su CW, Lee TY, Wang SY, Wu C, Wu JC. Association of nucleos(t)ide analogues therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.

Gastroenterology 2014 Jul; 147(1): 143-51.e5 (SCI, IF 33.883, 3/93; Gastroenterology & Hepatology).

97. Hsu YC, Wu CY, Lane HY, Chang CY, Tai CM, Tseng CH, Lo GH, Perng DS, Lin JT, Mo LR. Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B.

J Antimicrob Chemother 2014 Jul; 69(7): 1920-7 (SCI, IF 5.790, 42/275; Pharmacology).

98. Hsu YC, Lin JT, Ho HJ, Kao YH, Huang YT, Hsiao NW, Wu MS, Liu YY, Wu CY*. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.

Hepatology 2014 Apr; 59(4):1293-302 (SCI, IF 17.298, 6/93; Gastroenterology & Hepatology).

99. Huang SW, Kao JK, Wu CY, Wang ST, Lee HC, Liang SM, Chen YJ, Shieh JJ. Targeting aerobic glycosis and HIF-1 alpha expression enhance Imiquimod-induced apoptosis in cancer cells. Oncotarget 2014 Mar; 5(5): 1363-81.
100. Su CW, Wu CY (co-first author), Hung HH, Wu CH, Sheen IJ, Wu JC. Differential roles of serum HBV DNA and HBsAg level in predicting virological breakthrough in patients receiving lamivudine therapy.

J Gastroenterol Hepatol 2013 Dec;28(12):1849-58 (SCI, IF 4.369, 43/93; Gastroenterology & Hepatology).

101. Yeh CC, Lin JT, Jeng LB, Charalampos I, Chen TT, Lee TY, Wu MS, Kuo KN, Liu YY, Wu CY* (corresponding author) Hepatic resection for hepatocellular carcinoma patients on hemodialysis for uremia: a nationwide cohort study.

World J Surgery 2013 Oct; 37(10):2402-9 (SCI, IF 3.352, 66/211; Surgery).

102. Hsu YC, Ho HJ, Wu MS, Lin JT, Wu CY*. Postoperative peg-interferon plus ribavirin associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.

Hepatology 2013 Jul; 58(1): 150-7 (SCI, IF 17.298, 6/93; Gastroenterology & Hepatology).

103. Lee TY, Lin JT, Wu CC, Yu CC, Wu MS, Lee TC, Chen HP, Wu CY*. Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer.

J Clin Gastroenterol 2013 July;47(6): e55-9 (SCI, IF 3.174, 70/93; Gastroenterology & Hepatology).

104. Chen YJ, Wu CY (co-first), Shen JL, Chen TT, Chang YT. Association between traditional systemic anti-psoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: Results from a nationwide cohort study.

J Am Acad Dermatol 2013 Jul; 69(1):25-33 (SCI, IF 15.487, 1/68; Dermatology).

105. Hsu YC, Wu CY, Chang CY, Tai CM, Tseng CH, Perng DS, Mo LR, Lin JT. Pretreatment viral DNA stratifies mortality risk in patients receiving antiviral therapy for severe acute exacerbation of chronic hepatitis B.

Antiviral therapy 2013 Apr, 18(2): 221-8 (SCI, IF 2.146, 159/275; Pharmacology).

106. Chen HP, Shieh JJ, Chang CC, Chen TT, Lin JT, Wu MS, Lin JH, Wu CY*. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.

Gut 2013 Apr; 62(4): 606-15 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology).

107. Lin CY, Lane HY, Chen TT, Wu YH, Wu CY*(corresponding author), Wu V. Inverse association between cancer risks and age in Schizophrenia patients: a 12-year nationwide cohort study.

Cancer Sci 2013 Mar; 104(3): 383-90 (SCI, IF 6.716, 50/241; Oncology).

108. LeeTY, Lin JT, Kuo KN, Wu MS, Chen TT, Wu CY*. A rising trend in the incidence of cholangiocarcinoma: a nationwide cohort study.

Hepatol Int 2013 Mar; 7(1): 226-32 (SCI, IF 9.029, 16/93; Gastroenterology & Hepatology).

109. Lee TY, Yu CC, Wu CC, Chang CS, Lin JT, Wu MS, Chen HP, Wu CY*. MMP-9-1562 promoter polymorphism associated with gastric cancer risk in females

Hepatogastroenterology 2013 Feb 1; 60(126)

110. Huang SW, Wu CY (co-first author), Wang YT, Kao JK, Lin CC, Chang CC, Mu SW, Chen YY, Chiu HW, Chang Ch, Liang SM, Chen YJ, Huang JL, Shieh JJ. P53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells.

Toxicol Appl Pharmacol 2013 Feb 15, 267(1): 113-24 (SCI, IF 4.219, 96/275; Pharmacology)

111. Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, Lin JT. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma following liver resection.

JAMA 2012 Nov 12, 308(18): 1906-13 (SCI, IF 157.335, 3/172; Medicine, General & Internal).

112. Liao YJ, Wu CY, Lee SW, Lee CL, Yang SS, Chang CS, Lee TY. Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis.

World J Gastroenterol 2012 Oct; 18(37): 5260-5 (SCI, IF 5.374, 31/93; Gastroenterology & Hepatology).

113. Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY*(corresponding author). Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study.

Hepatology 2012 Aug 56(2): 698-705 (SCI, IF 17.298, 6/93; Gastroenterology & Hepatology).

114. Ho YF, Lin JT, Wu CY*. Oral bisphosphonates and risk of esophageal cancer: a dose-dependent analysis in a nationwide population.

Cancer Epidem Biomar Prev 2012 Jun; 21(6): 993-5 (SCI, IF 4.254, 51/293; Public, Environmental & Occupational health).

115. Chen YJ, Chang YT, Shen JL, Chen TT, Wang CB, Chen CM, Wu CY*. Association between systemic anti-psoriatic drugs and cardiovascular risk in patients with psoriasis and psoriatic arthritis: a nationwide cohort study.

Arthritis Rheum 2012 Jun;64(6):1879-87 (SCI, IF 10.995, 3/34; Rheumatology).

116. Huang SW, Chang CC, Lin CC, Tsai JJ, Chen YJ, Wu CY, Liu KT, Shieh JJ. Mcl-1 determines the imiquimod-induced apoptosis but not imiquimod-induced autophagy in skin cancer cells

J Dermatol Sci 2012 Mar; 65(3): 170-8 (SCI, IF 5.408, 9/68; Dermatology).

117. Chen YJ, Wu CY, Shen JL, Chen TT, Chang YT. Cancer risk in patients with chronic urticaria: a population-based cohort study.

JAMA Dermatol 2012 Jan; 148(1): 103-8 (SCI, IF 10.282, 2/68; Dermatology).

118. Sung JJ, Chan FK, Chen M, Ching JY, Ho LK, Kachintom U, Kim N, Lau JY, Menon J, Rani AA, Reddy N, Sollano J, Sugano K, Tsoi KK, Wu CY, Yeomans , Vakil N, Goh KL. Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding.

Gut 2011 Sep 60(9):1170-7 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology).

119. Chen YJ, Wu CY, Lin MW, Chen TJ, Liao KK, Chen YC, Hwang CY, Chu SY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study.

Br J Dermatol 2011 Sep; 165(3): 593-9 (SCI, IF 9.302, 3/68; Dermatology).

120. Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study.

Gut 2011 Aug; 60(8): 1038-42 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology).

121. Chen YJ, Wu CY (co-first author), Chen TJ, Shen JL, Chu SY, Wang CB, Chang YT. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.

J Am Acad Dermatol 2011 Jul; 65(1): 84-91 (SCI, IF 15.487, 1/68; Dermatology).

122. Chen YJ, Chang YT, Wang CB, Wu CY* (corresponding author). The risk of cancer in rheumatoid arthritis patients: a nationwide cohort study in Taiwan.

Arthritis Rheum 2011 Feb; 63(2):352-8 (SCI, IF 10.995, 3/34; Rheumatology).

123. Chen YJ, Chang YT, Wang CB, Wu CY*. Malignancy in systemic lupus erythematous: a nationwide cohort study in Taiwan.

Am J Med 2010 Dec;123(12):1150.e1-6 (SCI, IF 4.965, 30/167; Medicine, General & Internal)

124. Wu CY, Chan FK, Wu MS, Kuo KN, Wang CB, Tsao CR, Lin JT. Histamine-₂-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel.

Gastroenterology 2010 Oct; 139(4): 1165-71 (SCI, IF 33.883, 3/92; Gastroenterology & Hepatology).

125. Huang SW, Liu KT, Chang CC, Chen YJ, Wu CY, Tsai JJ, Lu WC, Want YT, Liu CM, Shieh JJ. Imiquimod simultaneously induces authophagy and apoptosis in human basal cell carcinoma cells.

Br J Dermatol 2010 Aug; 163(2): 310-20. (SCI, IF 9.302, 3/68; Dermatology).

126. Wu CY, Wu MS, Kuo KN, Chen YJ, Wang CB, Lin JT. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients.

J Clin Oncol 2010 Jun; 28(18): 2952-7. (SCI, IF 50.717, 6/245; Oncology)

127. Jung K, Wu CY. Methodological weakness in using correlation coefficients for assessing the interchangeability of analyte data between samples collected under different sampling conditions – the example of matrix metalloproteinase 9 determined in serum and plasma samples.

Clin Chem Lab Med 2010 May;48(5):733-6. (SCI, IF 3.009, 5/31; Biochemistry & Molecular Biology)

128. Chen YJ, Wu CY (co-first author), Huang YL, Wang CB, Shen JL, Chang YT. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.

Arthritis Research & Therapy 2010 Apr;12(2):R70. (SCI, IF 5.156, 9/34; Rheumatology)

129. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.

Gastroenterology 2009 Nov; 137(5):1641-8 (SCI, IF 33.883, 3/93; Gastroenterology & Hepatology).

130. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xioa SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA; Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.

J Gastroenterol Hepatol 2009 Oct;24(10):1587-600 (SCI, IF 4.369, 43/93; Gastroenterology & Hepatology).

131. Huang YL, Chen YJ, Lin MW, Wu CY, Liu PC, Chen TJ, Chen YC, Jih JS, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study.

Br J Dermatol 2009 Oct; 161(4): 854-60. (SCI, IF 9.302, 3/68; Dermatology).

132. Wu CY, Wu CH, Wu MS, Wang CB, Cheng JS, Kuo KN, Lin JT. A Nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H. pylori eradication and proton pump inhibitor.

Clin Gastroenterol Hepatol 2009 Apr;7(4):427-31 (SCI, IF 13.576, 7/93; Gastroenterology & Hepatology).

133. Chen YJ, Shen JL, Wu CY, Chang YT, Chen CM, Lee FY. Elevated plasma Osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis.

J Am Acad Dermatol 2009 Feb;60(2):2005-30 (SCI, IF 15.487, 1/68; Dermatology).

134. Chen YJ, Wu CY (co-first author), Shen JL, Chu SY, Chen CK, Chen CM, Chang YT. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.

JAMA Dermatol 2008 Dec; 144(12):1571-5. (SCI, IF 10.282, 2/68; Dermatology).

135. Weng SC, Wu CY*. Lymphoma presenting as peritoneal lymphomatosis with ascites.

J Chin Med Assoc 2008 Dec;25(2):210-4 (SCI, IF 2.743, 62/167; Medicine, General & Internal).

136. Wu CY, Wu MS, Chen CJ, Chen HP, Chen YJ, Chen GH, Lin JT. Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer.

Hepato-gastroenterology 2008 Sep-Oct;55(86-87):1890-4.

137. Lee YC, Liou JM, Wu MS, Wu CY, Lin JT. Eradication of Helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone.

Therap Adv Gastroenterol 2008 Sep; 1(2):111-20 (SCI, IF 4.409, 38/92; Gastroenterology & Hepatology).

138. Chen YJ, Wu CY, Chang CC, Ma CJ, Li MC, Chen CM. Nuclear Kruppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis.

Cancer Biol Ther 2008 May; 7(5):779-84 (SCI) (SCI, IF 4.742, 98/241; Oncology)

139. Weng SC, Wu CY*(corresponding author). Crohn’s disease complicated with intra-abdominal abscess: report of a case.

Advances in Digestive Medicine 2008;25(2): 210-4.

140. Liou JM, Lin JT, Lee YC, Wu CY, Wu MS. Helicobacter pylori infection the elderly.

International Journal of Gerontology 2008; 2(4): 145-53. (SCI)

141. Liou JM, Lin JT, Huang SP, Wu CY, Wang HP, Lee YC, Chiu HM, Shun CT, Lin MT, Wu MS. Rantes-403 polymorphism is associated with reduced risk of gastric cancer in women.

J Gastroenterol 2008 Feb; 43(2): 115-23. (SCI, IF 7.527, 17/92; Gastroenterology & Hepatology)

142. Liao WC, Lin JT, Wu CY, Huang SP, Lin MT, Wu AS, Huang YJ, Wu MS. Serum interleukin-6 level but not genotype predicts survival after resection in stage II and III gastric carcinoma.

Clin Cancer Res 2008 Jan; 14(2):428-34 (SCI, IF 12.531, 18/241; Oncology).

143. Wu CY, Wu MS, Chiang EP, Wu CC, Chen YJ, Chen CJ, Chi NH, Chen GH, Lin JT. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.

Gut 2007 Jun;56(6):782-9 (SCI, IF 31.793, 4/93; Gastroenterology & Hepatology).

144. Wu CY, Wu MS, Chiang EP, Chen YJ, Chen CJ, Chi NH, Shih YT, Chen GH, Lin JT. Plasma MMP-9 level is better than serum MMP-9 level to predict gastric cancer evolution.

Clinical Cancer Research 2007 Apr;13(7):2054-60 (SCI, IF 12.531, 18/241; Oncology).

145. Wu CY, Wu MS, Chen YJ, Chen CJ, Chen HP, Shun CT, Chen GH, Huang SP, Lin JT. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer.

Eur J of Cancer 2007 Mar;43(4):799-808. (SCI, IF 9.162, 33/241; Oncology)

146. Chen YJ, Wu CY*, JL Shen. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.

Acta Dermato-Venereologica 2007;87(1):33-8. (SCI, IF 4.437, 15/68; Dermatology)

147. Wu CY, Wu MS, Chen YJ, Chen CJ, Lin JT, Chen GH. Influence of COX-2 and local cytokine expressions in gastric ulcer mucosa by H pylori and NSAID.

Hepato-gastroenterology 2006 Sep;53(71):789-95.

148. Chang YH, Wang L, Lee MS, Cheng CW, Wu CY, Shiau MY. Genotypic characterization of Helicobacter pylori cagA and vacA from biopsy specimens of patients with gastroduodenal diseases.

Mt Sinai J Med 2006 May;73(3):622-6 (SCI).

149. Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, Lin JT, Inoue H, Chen GH. Helicobacter pylori promote gastric cancer cells invasion through a NF-kB and COX-2-mediated pathway. World J Gastroenterol 2005;11(21)3197-203. (SCI, IF 5.374, 31/93; Gastroenterology & Hepatology).
150. Wu CY, Wu MS, Chen CJ, Li MC, Lin JT, Chen GH. The interaction of H. pylori and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa and gastric ulcer edge.

J Clin Gastroenterol 2005;39(1):50-5 (SCI, IF 3.174, 70/93; Gastroenterology & Hepatology).

151. Wu CY, Chou LT, Chen HP, Chang CS, Wong PG, Chen GH. Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia.

Hepato-gastroenterol 2003;50(49):278-83.

152. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotype associate with the risk of gastric carcinoma in Taiwanese Chinese.

Int J Cancer 2003; 104(5): 617-23. (SCI, IF 7.396, 42/241; Oncology).  

153. Wu CY, Yeh HZ, Chen GH, Chang CS, Yang SS. Pharmacologcial efficacy in gastric variceal rebleeding and long term survival.

J Clin Gastroenterol 2002;35(2):127-32 (SCI, IF 3.174, 70/93; Gastroenterology & Hepatology).

154. Wu CY, Chen JT, Chen GH, Yeh HZ, Yang SS. Lymph node metastasis in early gastric cancer: a clinicopathological analysis.

Hepato-gastroenterol 2002; 49(47):1467-70.

155. Lee CC, Wu CY(corresponding author), Chen GH. What’s the impact of coexistence of hepatolithiasis on cholangiocarcinoma?

J Gastroenterol Hepatol 2002;17(9):1015-20 (SCI, IF 4.369, 43/93; Gastroenterology & Hepatology).

156. Lee CC, Wu CY(Corresponding author), Chen JT, Chen GH. Comparing combined hepatocellular- cholangiocarcinoma and cholangiocarcinoma: a clinicopathological study.

Hepato-gastroenterol 2002;49(48):1487-90

157. Ho SC, Wu CY* (corresponding author), Chang CS, Chen GH. Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease.

Dig Dis Sci 2002;47(3):652-6 (SCI, IF 3.199, 64/92; Gastroenterology & Hepatology).

158. Chang CS, Chou JW, Wu CY, Chang YH, Ko CW, Chen GH. Atropine-induced gastric dysrhythmia is not normalized by electroacupuncture.

Dig Dis Sci 2002;47(11):2466-72 (SCI, IF 3.199, 64/92; Gastroenterology & Hepatology).

159. Chang CS, Chou JW, Ko CW, Wu CY, Chen GH. Cutaneous electrical stimulation of acupuncture points may enhance gastric myoelectrical regularity.

Digestion 2002;66(2):106-11 (SCI, IF 3.216, 63/92; Gastroenterology & Hepatology)

160. Chang CS, Ko CW, Wu CY, Chen GH. Effect of electrical stimulation on acupuncture points in diabetic patients with gastric dysrhythmia: a pilot study.

Digestion 2001; 64(3): 184-90 (SCI, IF 3.216, 63/92; Gastroenterology & Hepatology)

161. Chou LT, Wu CY*, Chen HP, Chang CS, Wong PG, Ko CW, Chen GH. The correlation of depression and gastric dysrhythmia in functional dyspepsia.

J Clin Gastroenterol 2001;33(2)127-31 (SCI, IF 3.174, 70/93; Gastroenterology & Hepatology).

162. Chen YJ, Wu CY* (Corresponding author), Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.

British J Dermatol 2001;144(4):825-31. (SCI, IF 9.302, 3/68; Dermatology)

163. Wu CY, Tseng JJ, Chou MM, Poon SK, Lin SK, Chen GH. Correlation between Helicobacter pylori infection and gastrointestinal symptoms in pregnancy.

Adv Therapy 2000; 17(3):152-8 (SCI, IF 3.845, 119/275; Pharmacology).

164. Shiau MY, Tsai ST, Hwang J, Wu CY, Chang YH. Relationship between autoantibodies against glutamic acid decarboxylase, thyroglobulin/thyroid microsome and DNA topoisomerase II in the clinical manifestation of patients with type I diabetes mellitus in Taiwan.

Eur J Endocrinol 2000; 142(6): 577-85. (SCI)

165. Huang YH, Yeh HZ, Chen GH, Chang CS, Wu CY, Poon SK, Lien HC, Yang SS. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety.

Gastrointest Endosc 2000;52(2):160-7 (SCI, IF 9.427, 12/92; Gastroenterology & Hepatology)

166. Chen YJ, Wu CY, Chen JT, Shen JL, Chen CC, Wang HC. Clinicopathologic analysis of malignant melanoma in Taiwan.

J Am Acad Dermatol 1999;41(6): 945-9 (SCI, IF 15.487, 1/68; Dermatology).

167. Chen YJ, Wu CY, Chen JT, Shen JL. Nodular melanoma: a thirteen year clinical experience.

Dermatologica Sinica 1999;17(3): 200-7 (SCI, IF 1.321, 61/68; Dermatology)

168. Wu CY, Poon SK, Chen GH, Chang CS, Yeh HZ. Interaction between Helicobacter pylori and NSAID in peptic ulcer bleeding.

Scan J Gastroenterol 1999;34(3):234-7 (SCI, IF 2.423, 77/92; Gastroenterology & Hepatology)

169. Wu CY, Yeh HZ, Shih TP, Chen GH. Intraluminal mucin pool in mucinous gastric adenocarcinoma: a case report.

J Chin Med Assoc 1998; 61(11):673-7 (SCI, IF 2.743, 62/167; Medicine, General & Internal).

170. Wu CY, Poon SK, Chen GH. Is Helicobacter pylori a risk factor for NSAID-associated gastric ulcer bleeding? a sex- and age-matched case-control study.

Adv Therapy 1998; 15(2):85-91 (SCI, IF 3.845, 119/275; Pharmacology).

171. Wu CY, Yeh HZ, Shih TP, Chen GH. A clinicopathologic study of mucinous gastric carcinoma including multivariate analysis.

Cancer 1998; 83(7):1312-8. (SCI, IF 6.860, 48/241; Oncology).

172. Wu CY, Wang PY, Shen WC. Angiographic findings in Tolosa-Hunt syndrome: a case report.

J Chin Med Assoc 1995; 55(5):405-7 (SCI, IF 2.743, 62/167; Medicine, General & Internal).

Selected Publications in Law (in English)

1. Wu CY, Weng HC, Chen RC. Time Trends of Assessments for Medical Dispute Cases in Taiwan: A 20-year Nationwide Study. Intern Med J 2013 Sep;43(9): 1023-30 (SCI, IF 1.902, 52/154).
2. Wu CY, Lai HJ, Chen RC. Malpractice experience in Taiwan 1991 vs. 2005. Intern Med J 2009 Apr;39(4):237-42 (SCI, IF 1.902, 52/154).
3. Wu CY, Lai HJ, Chen RC. Patient characteristics predict occurrence and outcome of complaints against physicians: a study from a medical center in central Taiwan. J Formos Med Assoc 2009 Feb; 108(2):126-34 (SCI, IF 1.969, 46/154).